Company Filing History:
1 out of 484 
1 out of 4 Years Active: 2013
Title: The Innovations of Stephan Zbinden: A Pioneer in Microvasculature Research
Introduction: Stephan Zbinden, a distinguished inventor based in Wabern, Switzerland, has made significant contributions to the field of micro vasculature research. With one patent to his name, Zbinden’s innovative work is particularly focused on polypeptides that home to developing microvessels, a crucial area of study for understanding and treating various vascular conditions in humans.
Latest Patents: Zbinden’s patent, titled "Genes and proteins that home to developing microvessels," describes polypeptides that specifically target regions of developing microvasculature in mammals, especially humans. This groundbreaking invention includes DNA encoding these polypeptides, classified as developing microvasculature homing polypeptides. Notably, the collateral vessel endothelia (CVE) homing polypeptides have shown promising results in homing to collateral vessel endothelia after ischemia, opening new avenues for vascular therapy.
Career Highlights: Throughout his career, Stephan Zbinden has worked with reputable institutions that have bolstered his research endeavors. Notable among these are Georgetown University and MedStar Health Research Institute, Inc., where he has honed his expertise and contributed to pivotal research in vascular biology.
Collaborations: He has collaborated with esteemed colleagues such as Anton Wellstein and Marcel O. Schmidt, whose collective insights and expertise have enriched their shared research projects. These collaborations have played a significant role in advancing understanding in the area of microvascular development and its implications for human health.
Conclusion: Stephan Zbinden’s innovative contributions to the field of micro vasculature have positioned him as a key figure in this area of research. His dedication to exploring the complexities of polypeptides involved in microvascular development emphasizes the importance of such inventions in the advancement of medical science. As research continues to evolve, Zbinden’s work remains a significant touchstone for future innovations aimed at improving vascular health.